(+)-Afzelechin

Basic Information

View in Editor

CAS Number

2545-00-8

Molecular Formula

C15H14O5

Molecular Weight

274.27 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Ethers

Basic Chemical Raw Materials Organic Chemicals Heterocyclic Compounds

Pharmaceutical Chemicals Pharmaceutical Intermediates Heterocyclic Intermediates

Basic Physical Properties

Physical State

Powder

Solubility

N/A

SMILES

View in Editor

C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC=C(C=C3)O)O

InChI

InChI=1S/C15H14O5/c16-9-3-1-8(2-4-9)15-13(19)7-11-12(18)5-10(17)6-14(11)20-15/h1-6,13,15-19H,7H2/t13-,15+/m0/s1

InChIKey

RSYUFYQTACJFML-DZGCQCFKSA-N

LogP

1.8405000000000022

Topological Polar Surface Area

90.15 Å²

Hydrogen Bond Donor/Acceptor

4 / 5

Complexity

328

Safety Information

View Safety Information

Storage Conditions

2-8℃

Synonyms & References

English

(2R,3S)-2-(4-Hydroxyphenyl)-3,5,7-chromanetriol
CS-0023386
Q23068576
DTXSID60300139
NSC-135065
2H-1-Benzopyran-3,5,7-triol, 3,4-dihydro-2-(4-hydroxyphenyl)-, (2R,3S)-
SCHEMBL445728
MS-23892
LMPK12020035
AFZELECHIN
C09320
(+)-Afzelechin ;NSC 135065
AKOS032948423
3,5,7,4'-Tetrahydroxyflavan
UNII-W782YDV47U
3,4',5,7-Flavantetrol, (+)-
2545-00-8
GLXC-17295
HY-N2821
CHEMBL3437595
W782YDV47U
2H-1-Benzopyran-3,5,7-triol, 3,4-dihydro-2-(4-hydroxyphenyl)-, (2R-trans)-
(2R,3S)-afzelechin
(+)-Afzelechin
CHEBI:2507
(2R,3S)-2-(4-hydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol
CHROMIUMPOTASSIUMSULFATE
2H-1-Benzopyran-3,5,7-triol,3,4-dihydro-2-(4-hydroxyphenyl)-, (2R,3S)-
2-(4-hydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol
Afzelechin
[ "" ]

MDL Number

MFCD01861520

FAQ

What regulatory guidelines apply to (+)-Afzelechin (CAS: 2545-00-8)?

Regulatory guidelines for (+)-Afzelechin (CAS: 2545-00-8) include GHS classification which categorizes it as a substance of very high concern due to its potential health effects. Under REACH regulations, it requires pre-market registration and evaluation by the European Chemicals Agency (ECHA). FDA and EPA may also have specific requirements for its import, distribution, and use in the United States, focusing on safety and environmental impact.

Are there alternatives to (+)-Afzelechin (CAS: 2545-00-8) in synthesis?

In synthesis, alternatives to (+)-Afzelechin (CAS: 2545-00-8) may include other flavonoids such as apigenin or luteolin. Isomers like (–)-Afzelechin or related compounds like naringenin can also be considered. Common alternative reagents for synthesis might include hydroxycinnamic acid derivatives or other plant-based compounds with similar structural features.

What is the market or research trend for (+)-Afzelechin (CAS: 2545-00-8)?

The market and research trend for (+)-Afzelechin (CAS: 2545-00-8) focuses on its potential use in medical research, particularly in the treatment of inflammatory conditions and cancer. Recent studies highlight its antioxidant and anti-inflammatory properties, driving interest in its therapeutic applications. Market trends indicate increasing demand for natural product extracts rich in (+)-Afzelechin.

How should waste containing (+)-Afzelechin (CAS: 2545-00-8) be handled?

Waste containing (+)-Afzelechin (CAS: 2545-00-8) should be collected in appropriate containers and stored separately to prevent contamination. For disposal, professional waste disposal services should be contacted. Incineration or chemical treatment methods can be used to destroy the compound, ensuring compliance with environmental protection laws. Always follow local regulations and safety guidelines when handling and disposing of waste containing (+)-Afzelechin.